The influence of sex on the prognostic value of body mass index in non-metastasis renal cell carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387(10021):894–906. doi:10.1016/S0140-6736(15)00046-X26318520
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–924. doi:10.1016/j.eururo.2015.01.00525616710
   PubMed Web of Science ®Google Scholar
• Chiong E, Tay MH, Tan MH, et al. Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol. 2012;13(11):e482–e491. doi:10.1016/S1470-2045(12)70433-323117003
   PubMed Web of Science ®Google Scholar
• Mathew A, Devesa SS, Fraumeni JF Jr. , Chow WH. Global increases in kidney cancer incidence, 1973–1992. Eur J Cancer Prev. 2002;11(2):171–178. doi:10.1097/00008469-200204000-0001011984136
   PubMed Web of Science ®Google Scholar
• Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7(5):245–257. doi:10.1038/nrurol.2010.4620448658
   PubMed Web of Science ®Google Scholar
• Adams KF, Leitzmann MF, Albanes D, et al. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol. 2008;168(3):268–277. doi:10.1093/aje/kwn12218544571
   PubMed Web of Science ®Google Scholar
• Hakimi AA, Furberg H, Zabor EC, et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst. 2013;105(24):1862–1870. doi:10.1093/jnci/djt31024285872
   PubMedGoogle Scholar
• Ather MH, Nazim SM. Impact of Charlson‘s comorbidity index on overall survival following tumor nephrectomy for renal cell carcinoma. Int Urol Nephrol. 2010;42(2):299–303. doi:10.1007/s11255-009-9636-819714477
   PubMed Web of Science ®Google Scholar
• Donat SM, Salzhauer EW, Mitra N, Yanke BV, Snyder ME, Russo P. Impact of body mass index on survival of patients with surgically treated renal cell carcinoma. J Urol. 2006;175(1):46–52. doi:10.1016/S0022-5347(05)00054-616406867
   PubMed Web of Science ®Google Scholar
• Steffens S, Ringe KI, Schroeer K, et al. Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study. Int J Urol. 2013;20(6):585–592. doi:10.1111/iju.1200023176631
   PubMed Web of Science ®Google Scholar
• Komura K, Inamoto T, Black PC, et al. Prognostic significance of body mass index in Asian patients with localized renal cell carcinoma. Nutr Cancer. 2011;63(6):908–915. doi:10.1080/01635581.2011.59420721800976
   PubMed Web of Science ®Google Scholar
• Bagheri M, Speakman JR, Shemirani F, Djafarian K. Renal cell carcinoma survival and body mass index: a dose-response meta-analysis reveals another potential paradox within a paradox. Int J Obes (Lond). 2016;40(12):1817–1822. doi:10.1038/ijo.2016.17127686524
   PubMed Web of Science ®Google Scholar
• Ito R, Narita S, Huang M, et al. The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: a potential mechanism for the “obesity paradox”. PLoS One. 2017;12(2):e0171615. doi:10.1371/journal.pone.017161528178338
   PubMed Web of Science ®Google Scholar
• Shen T, Shu XO, Xiang YB, et al. Association of hypertension and obesity with renal cell carcinoma risk: a report from the Shanghai men‘s and women‘s health studies. Cancer Causes Control. 2015;26(8):1173–1180. doi:10.1007/s10552-015-0611-726081424
   PubMed Web of Science ®Google Scholar
• Byun SS, Hwang EC, Kang SH, et al. Sex-specific prognostic significance of obesity in nonmetastatic clear-cell renal-cell carcinoma in Korea: a large multicenter cohort analysis. Clin Genitourin Cancer. 2017;16(1):e173–e179. doi:10.1016/j.clgc.2017.08.015
   Web of Science ®Google Scholar
• Ohno Y, Nakashima J, Nakagami Y, et al. Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma. Br J Cancer. 2013;109(7):1899–1903. doi:10.1038/bjc.2013.51224002606
   PubMed Web of Science ®Google Scholar
• Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation. 2007;115(16):2111–2118. doi:10.1161/CIRCULATIONAHA.106.63501117420343
   PubMed Web of Science ®Google Scholar
• Park SK, Ryoo JH, Oh CM, et al. Effect of overweight and obesity (Defined by Asian-specific cutoff criteria) on left ventricular diastolic function and structure in a General Korean population. Circ j. 2016;80(12):2489–2495. doi:10.1253/circj.CJ-16-062527773890
   PubMed Web of Science ®Google Scholar
• World Health Organization, International Obesity Task Force. The Asian-Pacific Perspective: Redefining Obesity and Its Treatment. Geneva, Switzerland: WHO Western Pacific Region; 2000.
   Google Scholar
• Choi Y, Park B, Jeong BC, et al. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer. 2013;132(3):625–634. doi:10.1002/ijc.2763922610826
   PubMed Web of Science ®Google Scholar
• Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. Bmj. 2007;335(7630):1134. doi:10.1136/bmj.39367.495995.AE17986716
   PubMed Web of Science ®Google Scholar
• Gurunathan U, Myles PS. Limitations of body mass index as an obesity measure of perioperative risk. Br J Anaesth. 2016;116(3):319–321. doi:10.1093/bja/aev54126865129
   PubMed Web of Science ®Google Scholar
• Astrup A. Physical activity and weight gain and fat distribution changes with menopause: current evidence and research issues. Med Sci Sports Exerc. 1999;31(11 Suppl):S564–S567. 10593529
   PubMed Web of Science ®Google Scholar
• Lucca I, Klatte T, Fajkovic H, de Martino M, Shariat SF. Gender differences in incidence and outcomes of urothelial and kidney cancer. Nat Rev Urol. 2015;12(10):585–592. doi:10.1038/nrurol.2015.23226436686
   PubMed Web of Science ®Google Scholar
• Haake SM, Hacker KE, Pruthi RS, Wallen EM, Nielsen ME, Rathmell WK. Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology.%A Brannon AR. Eur Urol. 2012;61(2):258–268. doi:10.1016/j.eururo.2011.10.00722030119
   PubMed Web of Science ®Google Scholar
• Linehan WM. Gender specific mutation incidence and survival associations in clear cell renal cell Carcinoma (CCRCC).%A ricketts CJ. PLoS One. 2015;10(10):e0140257. doi:10.1371/journal.pone.014025726484545
   PubMed Web of Science ®Google Scholar